Self-assembling two-antibody strategy may help chemo reach ADC-resistant tumors
WmHaseltine · x · 2026-09-24
A new study proposes a self-assembling two-antibody strategy: two antibodies assemble in the body, potentially helping chemotherapy reach tumors that evade conventional antibody-drug conjugates (ADCs). It offers a new delivery route for ADC-resistant cancer.
More from Research
- BFL shows FLUX 3 Action flying a simulated drone, hinting at broader uses — bfl_ai · 2026-09-24
- BFL open-sources 7B world action model FLUX 3 Action, tops RoboLab 6.1pp ahead — bfl_ai · 2026-09-24
- IKEA Assembly Benchmark: Top Model Score Jumped From 28% to 80% in 10 Months — emollick · 2026-09-24
- Juan Perdomo, researcher on performative prediction, joins NYU as assistant professor — thegautamkamath · 2026-09-24
- Claude Opus 5.5 and GPT-6 Sol land on Biomni Lab research platform — KexinHuang5 · 2026-09-24
- JevK5 open decision model ranks #2 of 76 on JevBench, outputs calibrated probabilities in ~13ms — airesearch12 · 2026-09-24